NAD+: The Molecule Behind Cellular Energy and Repair

LEGAL & MEDICAL DISCLAIMER: The information provided on this page by PeptideMatch.io is intended solely for educational and informational purposes. It does not constitute, and should not be interpreted as, professional medical advice, diagnosis, or treatment. Always consult a licensed physician or qualified healthcare provider before beginning any peptide therapy or making changes to an existing treatment plan. PeptideMatch.io does not prescribe, dispense, or endorse any specific therapeutic protocol. Individual results may vary, and no outcomes are guaranteed.

What Is NAD+?

In 1937, a physician named Conrad Elvehjem discovered that a disease called pellagra (which causes skin rashes, diarrhea, and confusion) was caused by a simple nutritional gap. The missing piece was niacin, a building block of a molecule called nicotinamide adenine dinucleotide, or NAD+.¹

Nearly a century later, that same molecule has become one of the most studied compounds in aging science. Not because it is new, but because researchers have only recently begun to see just how central it is to nearly everything a cell does.

NAD+ is a helper molecule found in every living cell. It plays a role in hundreds of chemical reactions, helps enzymes repair damaged DNA, and acts as a signal that affects how cells age, handle stress, and keep their energy levels up. Without enough NAD+, cells struggle to make energy, fix damage, or control inflammation.¹

What makes NAD+ especially interesting is a straightforward finding: its levels go down as we get older. That drop has been linked to many age-related problems, from slowed metabolism to memory decline. And raising those levels back up, either through supplements taken by mouth or through IV drips given in a clinic, has become a major focus of longevity research.²

Fast Facts

FULL NAME	Nicotinamide adenine dinucleotide (NAD+)
CLASS	Coenzyme; metabolic cofactor
PRIMARY ACTION	Helps power energy production, supports DNA repair enzymes (sirtuins and PARPs), and plays a role in immune signaling
ADMINISTRATION	In clinical studies, administered orally as NR or NMN supplements; also studied as an IV infusion in clinical settings
HALF-LIFE	Depends on the form; oral precursors reach peak blood levels within 1 to 3 hours
RESEARCH	Age-related NAD+ decline, metabolic health, brain protection, DNA repair, cellular aging
REGULATORY STATUS	NAD+ precursors (NR) are sold as dietary supplements; NMN regulatory status is under FDA review; NAD+ itself is not approved as a drug

How Does NAD+ Work?

NAD+ is involved in several key processes inside your cells. Rather than doing one thing, it helps keep many systems running at the same time. Here are the three most important roles it plays:

1. Helping Cells Make Energy NAD+ carries electrons (tiny charged particles) between chemical reactions that turn food into fuel. Think of it like a delivery truck that moves energy from one step of the process to the next. The end result is ATP, the molecule your cells actually burn for power. When NAD+ levels are low, this delivery system slows down, and cells cannot turn food into energy as well.¹
2. Turning On Repair Enzymes (Sirtuins) Sirtuins are a group of seven enzymes that help repair DNA, reduce inflammation, and keep metabolism in balance. But they cannot work without NAD+. It is their required fuel. When NAD+ levels drop, sirtuin activity drops too, and the cell loses some of its ability to fix damage and manage stress.¹
3. Supporting DNA Repair (PARPs) PARPs are another set of enzymes whose job is to find and fix broken DNA. They use up NAD+ every time they make a repair. As we age, DNA damage builds up, so PARPs work harder and consume more NAD+. This creates a cycle: the more repairs are needed, the less NAD+ is left over for other important jobs like energy production and sirtuin activity.¹

The research on NAD+ is growing quickly, with studies ranging from lab work to human clinical trials. PeptideMatch.io presents this data to help our community understand the current state of evidence and the difference between early findings and confirmed results in people.

THERAPEUTIC AREA	WHAT RESEARCH SUGGESTS	EVIDENCE LEVEL
NAD+ Restoration	Oral NR supplements raised blood NAD+ levels significantly in healthy middle-aged and older adults over six weeks.2	Clinical
Metabolic Health	NMN supplements in clinical trials were linked to improvements in markers of metabolic function and NAD+ production.3	Clinical
Skeletal Muscle	NR supplements in older adults increased NAD+ levels in muscle tissue and activated anti-inflammatory gene patterns.4	Clinical
Brain Health	Early human data suggest NAD+ precursors may support thinking and memory, though large confirming trials are still underway.5	Early Clinical
Safety & Tolerability	A review of multiple trials found oral NAD+ precursors (NR, NMN) were generally well-tolerated with few side effects.	Clinical

Key Clinical Findings

One of the landmark human studies was done by Martens and colleagues in 2018. In a randomized, placebo-controlled trial, healthy adults aged 55 to 79 took 1,000 mg of nicotinamide riboside (NR) daily for six weeks. The study found that NR was well-tolerated and successfully raised NAD+ levels in blood cells. Researchers also saw trends toward better heart health markers, though the study was too small to confirm those benefits.²

A separate 2019 study by Elhassan and colleagues looked at NR supplements in older adults and focused on muscle tissue. The trial found that NR raised NAD+ levels in muscle and turned on genes linked to reduced inflammation and better antioxidant defense. This suggests that raising NAD+ may have effects in specific tissues beyond just the bloodstream.⁴

Across multiple clinical trials, oral NAD+ precursors (NR and NMN, taken as pills or capsules) have generally been reported as safe and well-tolerated. A 2024 review of randomized trials found that the most common side effects were mild and included stomach discomfort, tiredness, and occasional trouble sleeping.⁶

For NAD+ given through an IV drip (where the compound goes directly into a vein at a clinic), a 2026 study found that patients experienced moderate but short-lived discomfort during the infusion itself, including stomach cramps, nausea, and chest tightness. These symptoms went away as soon as the drip was stopped, and no lasting problems were reported up to 30 days later.⁷

Long-term safety data (beyond 12 weeks) in humans is still limited for both oral and IV forms. Some researchers have raised a theoretical question: because NAD+ helps all cells make energy, could raising its levels also give a boost to cancer cells, which grow and divide quickly? This has not been seen in any human study to date, but it is something scientists continue to watch for. As with any new approach, individual responses can vary.

Important Considerations

Regulatory Status	NR (nicotinamide riboside) is sold as a dietary supplement. NMN’s status is under FDA review. NAD+ itself is not approved as a drug for any condition.
What We Still Don’t Know	Short-term studies show NAD+ precursors can raise blood NAD+ levels, but whether this prevents disease or extends lifespan has not yet been confirmed in large human trials.
Medical Oversight	NAD+ supplementation, especially IV drips, should be done under the guidance of a qualified healthcare provider who can assess your individual health and watch for any issues.
Quality and Source	The supplement market for NAD+ precursors varies widely in quality. Look for products with third-party testing and clear information about where and how they are made.

The Bottom Line: NAD+ is not a new molecule. It has been known to science for over a century. What is new is our understanding of how much it declines with age, the impact that has on how cells work, and how increasing the levels may change the course of age-related conditions. The clinical evidence so far confirms that NAD+ precursors can effectively raise NAD+ levels in humans and appear to be safe in the short term. Whether this leads to real health benefits for aging, brain health, or metabolism is still being studied. For those interested in the science of aging and cellular health, NAD+ is one of the best-understood targets in longevity research, and the gap between lab findings and real-world results is getting smaller every year.

Scientific References

1. Covarrubias AJ, Perrone R, Grozio A, Verdin E. NAD+ metabolism and its roles in cellular processes during ageing. Nature Reviews Molecular Cell Biology. 2021;22(2):119-141.
2. Martens CR, Denman BA, Mazzo MR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nature Communications. 2018;9(1):1286.
3. Song Q, Zhou X, Xu K, Liu S, Zhu X, Yang J. The safety and antiaging effects of nicotinamide mononucleotide in human clinical trials: an update. Advances in Nutrition. 2023;14(6):1416-1435.
4. Elhassan YS, Kluckova K, Fletcher RS, et al. Nicotinamide riboside augments the aged human skeletal muscle NAD+ metabolome and induces transcriptomic and anti-inflammatory signatures. Cell Reports. 2019;28(7):1717-1728.
5. Wu CY, Chen YF, Wang CH, et al. Effects of nicotinamide riboside on NAD+ levels, cognition, and brain function: a systematic review. eClinicalMedicine. 2025;79:103007.
6. Gindri IM, de Moura Sperotto ND, Bhatt NP, et al. Evaluation of safety and effectiveness of NAD in different clinical conditions: a systematic review. American Journal of Physiology-Endocrinology and Metabolism. 2024;326(3):E208-E220.
7. Reyna K, Legere H, Pojednic R. Intravenous infusion of nicotinamide adenine dinucleotide (NAD+) versus nicotinamide riboside (NR): a retrospective tolerability pilot study in a real-world setting. Frontiers in Aging. 2026;7:1652582.

©2026 PeptideMatch.io. All Rights Reserved. This educational content is the exclusive intellectual property of PeptideMatch.io. Reproduction, distribution, republication, or transmission of this material, in whole or in part, in any form or by any means, is strictly prohibited without the prior written consent of PeptideMatch.io. For licensing or reprint inquiries, please contact content@peptidematch.io.